Compensatory function of bradykinin B1 receptor in the inhibitory effect of captopril on cardiomyocyte hypertrophy and cardiac fibroblast proliferation in neonatal rats

Chinese Medical Journal

Volumn 121, Issue 13, 2008, Pages 1220-1225

  Zou, Jun ^a   Ren, Jiang Hua ^a   Feng, Dan ^b   Wang, Hong ^a   Xu, Jiang ^b  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Bradykinin; Captopril; Cardiac fibroblast; Cardiomyocyte

Indexed keywords

ANGIOTENSIN II; ARGININE DERIVATIVE; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; CAPTOPRIL; CYCLIC GMP; ICATIBANT; KALLIDIN; LEUCINE; NITRIC OXIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SIZE; COLORIMETRY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FIBROBLAST; FLOW CYTOMETRY; HEART HYPERTROPHY; HEART MUSCLE CELL; INCUBATION TIME; NEWBORN; NONHUMAN; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RAT; RECEPTOR BLOCKING; ANIMAL; BIOSYNTHESIS; CARDIOMEGALY; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; CAPTOPRIL; CARDIOMEGALY; CELL PROLIFERATION; CELL SIZE; CYCLIC GMP; DNA; FIBROBLASTS; MYOCYTES, CARDIAC; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B1;

EID: 50549092639     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200807010-00014     Document Type: Article

References (31)

1. Lorell BH, Caraballo BA. Left ventricular hypertrophy, pathogenesis, detection, and prognosis. Circulation 2000; 102: 470-479.
2. Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation 1998; 97: 1411-1420.
3. Xu J, Carretero OA, Liu YH, Yang F, Shesely EG, Oja-Tebbe N, et al. Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure. J Card Fail 2004; 10: 83-89.
4. Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 2005; 99: 6-38.
5. Marceau F, Hess JF, Bachvarov DR. The B, receptors for kinins. Pharmacol Rev 1998; 50: 357-386.
6. 2 receptor stimulation. Circulation 2000; 101: 1848-1853.
7. 1 receptor gene in inflammation. J Biol Chem 1998; 273: 2784-2791.
8. 1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. Cardiovasc Res 2004; 61: 559-569.
9. Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med 1998; 76: 725-746.
10. Huang J, Qin GH, Hu CX, Gong LY, Cheng FZ, Ma YX, et al. Effects of transforming growth factor-betal and signal protein Smad3 on rat cardiomyocyte hypertrophy. Chin Med J 2004; 117: 1471-1475.
11. Rosenkranz AC, Hood SG, Woods RL, Dusting GJ, Ritchie RH, Acute antihypertrophic actions of bradykinin in the rat hear. Importance of cyclic GMP. Hypertension 2002; 40: 498-503.
12. Kim NN, Villegas S, Summerour SR, Villarreal FJ. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide. J Mol Cell Cardiol 1999; 31: 457-466.
13. Murphey L, Vaughan D, Brown N. Contribution of bradykinin to the cardioprotective effects of ACE, inhibitors. Eur Heart J 2003. 5 Suppl A: A37-A41.
14. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts.Critical role of the AT1 receptor subtype. Circ Res 1993; 73: 413-423.
15. Crissman HA, Darzynkiewicz Z, Tobey RA, Steinkamp JA. Normal and perturbed Chinese hamster ovary cells: correlation of DNA, RNA and protein content by flow cytometry. J Cell Biol 1985; 101: 141-147.
16. 2 kinin receptor gene knockout mice. Circ Res 2001; 88: 1072-1079.
17. Feng D, Xu J, Zou J. Influence of bradykinin to the antiproliferative effects of captopril on cardiac fibroblasts in neonatal rats. J Clin Cardiol (Chin) 2005; 21: 552-554.
18. Nolly H, Carbini LA, Scicli G, Carretero OA, Scicli AG. A local kallikrein-kinin system is present in rat hearts. Hypertension 1994; 23: 919-923.
19. 1 receptor by ACE inhibitors. Int Immunopharmacol 2002; 2: 1787-1793,
20. Kintsurashvili E, Duka I, Gavras I, Johns C, Farmakiotis D, Gavras H. Effects of Ang II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2001; 281: H1778-H1783.
21. Ignjacev-Lazich I, Kintsurashvili E, Johns C, Vitseva O, Duka A, Shenouda S, et al. Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol Heart Circ Physiol 2005; 289: H1814-H1820.
22. Duka I, Kintsurashvili E, Gavras I, Johns C, Bresnahan M, Gavras H. Vasoactive potential of the B, bradykinin receptor in normtension and hypertension. Circ Res 2001; 88: 275-281.
23. 2 receptors in normal blood pressure regulation. Am J Physiol Endocrinol Metab 2006; 291: E268-E274.
24. 1-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment. Circulation. 2002; 105: 627-632.
25. 1 receptor. Br J Pbarmacol 2004; 141: 728-736.
26. 1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension 2005; 45: 747-753.
27. 1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by ACE inhibitors and peptide ligands. Mol Pharmacol 2004; 66: 1310-1316.
28. Agata J, Miao RQ, Yayama K, Chao L, Chao J. Bradykinin B, receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension 2000; 36: 364-370.
29. 1 - receptor-induced hypotension in the anesthetized dog. J Cardiovase Pharmacol 1996; 28: 645-650.
30. Fleming I. Signaling by the angiotensin-converting enzyme. Circ Res 2006; 98: 887-896.
31. 1 receptors in myocardial ischemia:evidence from pharmacological blockade and gene knockout mice. Int Immunopharmacol 2002; 2: 815-822.